# CNN’s @drsanjaygupta Talks to a Developmental Neuroscientist on Marijuana Use > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-neurodevelopmental-risk-adolescents-young-adults/ > **Published:** 2026-04-17T15:03:23-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:19:42-04:00 > **Clinical Summary:** Explore cannabis neurodevelopmental risk and its impact on adolescent brain development and cognitive function in this expert discussion. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchMental HealthSafety Why This Matters Clinicians need to understand cannabis’s effects on brain development and neuroplasticity to counsel patients, particularly adolescents and young adults whose brains remain vulnerable to structural and functional changes. Knowledge of these documented neurodevelopmental effects enables providers to make informed recommendations about [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and to identify patients at risk for cognitive or developmental complications. This evidence supports clinical conversations about the distinction between short-term psychoactive effects and potentially lasting neural consequences that should inform shared decision-making around cannabis use. Clinical Summary This article highlights emerging neuroscience research on cannabis’s potential effects on brain development and structure, particularly regarding long-term use patterns. While cannabis is increasingly used for medical purposes, the evidence suggests that regular consumption may produce measurable changes in brain function and connectivity beyond acute intoxication effects. The CDC’s 2024 guidance emphasizes that these neurobiological changes warrant careful consideration, especially in adolescents and young adults whose brains continue developing into the mid-twenties. Clinicians prescribing cannabis should counsel patients about these potential neurodevelopmental risks and monitor for cognitive or behavioral changes during treatment. For patients considering cannabis use, particularly those in vulnerable developmental windows, understanding that brain effects may extend beyond symptom relief should inform shared decision-making about whether and how to use the drug. Dr. Caplan’s Take “What we’re seeing in the neuroimaging literature is that regular cannabis use during critical developmental windows can alter white matter integrity and prefrontal cortex maturation, which is why I counsel my adolescent patients and their parents with particular urgency about the timing and frequency of use, not just whether to use at all.” Clinical Perspective Growing evidence from developmental neuroscience suggests that regular cannabis use, particularly during adolescence and early adulthood, may alter brain structure and function in ways that extend beyond acute intoxication. However, clinicians should recognize that most human studies remain observational, making it difficult to definitively separate cannabis-related effects from confounding factors such as underlying psychiatric conditions, concurrent substance use, socioeconomic stress, or genetic predisposition to brain changes. The dose, frequency, potency (particularly THC concentration), age of initiation, and individual vulnerability factors all likely modulate neurodevelopmental risk in ways that current research has not fully characterized. Despite these gaps, the biological plausibility of cannabis-induced neural changes warrants counseling patients, especially adolescents and young adults, about potential long-term cognitive and mental health consequences during discussions about use initiation or continuation. Clinicians should integrate this evolving neuroscience into risk- 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/medical-illness/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+CNN%27s+%40drsanjaygupta+talks+to+a+Developmental+Neuroscientist+studying+marijuana+use+...+%40drcaplan&url=https%3A%2F%2Fwww.instagram.com%2Freel%2FDXPcGTjDvC2%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.instagram.com%2Freel%2FDXPcGTjDvC2%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+CNN%27s+%40drsanjaygupta+talks+to+a+Developmental+Neuroscientist+studying+marijuana+use+...+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.instagram.com%2Freel%2FDXPcGTjDvC2%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.instagram.com/reel/DXPcGTjDvC2/](https://www.instagram.com/reel/DXPcGTjDvC2/) Further Reading Evidence Watch[Cannabis Users Show Higher Testicular Androgen Levels, New Steroid Profiling Study Finds](https://cedclinic.com/steroid-profiling-cannabis-young-men-2026/) CED Clinic BlogButterfly numbers are dropping but here are five species you may see more of Cannabis Policy Wire[Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I](https://cedclinic.com/4-fluoroamphetamine-schedule-i-placement/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Teen Marijuana Use Doubles Chances of Future Psychotic Disorders, Study Finds](https://cedclinic.com/adolescent-cannabis-use-psychotic-risk-study/) This study reveals how [teen marijuana use](https://cedclinic.com/adolescent-cannabis-neurodevelopmental-risk-teens/) significantly increases the risk of developing psychotic disorders later in life. [Read Study Insights](https://cedclinic.com/adolescent-cannabis-use-psychotic-risk-study/) [Long-Term Heavy Cannabis Use Linked to Subtle Changes in Brain Structure](https://cedclinic.com/chronic-heavy-cannabis-use-brain-changes/) Explore research showing how prolonged heavy cannabis use can alter brain structure beyond acute effects. [Explore Brain Research](https://cedclinic.com/chronic-heavy-cannabis-use-brain-changes/) [Study of 11,000 US Teens Links Cannabis Use to Slower Brain Development – Science Alert](https://cedclinic.com/cannabis-use-adolescent-brain-maturation-risks-study/) A large-scale study connecting [cannabis use in teens](https://cedclinic.com/stress-cannabis-use-adolescents-covid19-impact/) with delayed brain development and cognitive function. [Learn More](https://cedclinic.com/cannabis-use-adolescent-brain-maturation-risks-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).